retatrutide trial results news today This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond Amid the growing demand for

Medication interactions and absorption issues may arise with some GLP-1 medications

The Estonian Biobank Research Team responsible for data collection, genotyping, QC and imputation: A

Glucagon-like peptide-1 (GLP-1) is a glucoregulatory hormone synthetized in the intestines and the brain, involved in the maintenance of energy homeostasis mainly by stimulating insulin secretion and regulation of appetite

Rounding out the top five sponsors in the clinicaltrials.gov dataset were Pfizer, Sanofi and Yale

What is the safest weight loss option while breastfeeding

Nausea, the most common side effect occurring in 15-30% of patients depending on dose, typically peaks during the first few weeks after dose initiation or escalation and often improves with continued use